Prevalence of Diastolic Dysfunction Among COPD Patients—A Systematic Review and Meta‐Analysis
Pulmonary Medicine · 2026-01 · 2026 (1)
DOI: 10.1155/pm/5113702 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pulmonary Medicine, online erschienen am 19.11.2026. Verfasst von Sanjay Singhal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India, sgpgi.ac.in. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Ventricular Dysfunction, Left. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: COPD
Abstract (Originalsprache)
Background
Given the similarity of risk factors and pathophysiological mechanisms, suspecting HFpEF in COPD is challenging because of overlapping clinical features. Echocardiographic assessment of diastolic dysfunction (DD) may help identify patients with abnormal left ventricular filling who warrant further cardiac evaluation, although DD is not equivalent to a clinical diagnosis of HFpEF. We conducted a systematic review and meta‐analysis to estimate the pooled prevalence of DD among patients with COPD.
Methods
PubMed, EMBASE, Scopus, and Cochrane databases were searched from inception to February 5, 2026. Studies reporting the prevalence of DD in COPD using any echocardiographic criteria were included. A random‐effects meta‐analysis was performed using restricted maximum‐likelihood estimation. Heterogeneity was assessed with Cochran′s Q , I 2 , and τ 2 . Subgroup, sensitivity, and meta‐regression analyses were conducted. Study quality was assessed using the Newcastle–Ottawa scale, and the certainty of the evidence was evaluated using the GRADE approach.
Results
Forty‐eight studies comprising 6845 patients were included. The pooled prevalence of echocardiographic findings consistent with DD was 47% (95% CI: 39%–56%), with substantial between‐study heterogeneity ( I 2 = 95.5%; 95% prediction interval, 7%–91%). Prevalence increased across GOLD stages, from 30% (95% CI: 16%–50%) in Stage I to 38% (22%–57%) in Stage II, 58% (39%–75%) in Stage III and 72% (56%–84%) in Stage IV. These stage‐specific estimates were interpreted descriptively because several studies contributed data to multiple stages. Sensitivity analyses yielded pooled prevalences of 54% after excluding low‐quality studies and 62% after excluding studies with fewer than 50 participants. Multivariable meta‐regression explained only a modest proportion of between‐study variance. No statistically significant asymmetry was detected by Egger′s test, although its interpretation for prevalence outcomes is limited. Overall certainty of evidence was low.
Conclusions
Echocardiographic findings consistent with DD are frequently reported among patients with COPD, but the absolute pooled prevalence is uncertain because of substantial heterogeneity, variation in echocardiographic definitions and predominantly low study quality. A severity‐associated increase across GOLD stages was observed but should be interpreted descriptively because of nonindependent subgroup data. Further prospective studies using standardized echocardiographic definitions and comprehensive cardiopulmonary phenotyping are required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India, sgpgi.ac.in.
- All India Institute of Medical Sciences, Raipur, India, aiims.edu.
- All India Institute of Medical Sciences, Rajkot, India, aiims.edu.
- Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, India, drrmlims.ac.in.
- King George's Medical University, Lucknow, India, kgmu.edu.in.
- TS Misra Medical College and Hospital, Lucknow, India.
ORCID-Profile: Sanjay Singhal, Ranganath Ganga, Kunal Deokar, Jayvardhan Singh, Ashish Jha, Mranalini Verma, Anup Kumar, Piyush Shrivastava, Shiv Kumar Mudgal, Mohan Gurjar
Zitieren
APA
Singhal, S., Ganga, R., Deokar, K., Singh, J., Jha, A., Verma, M., Kumar, A., Shrivastava, P., Mudgal, S. K., & Gurjar, M. (2026). Prevalence of Diastolic Dysfunction Among COPD Patients—A Systematic Review and Meta‐Analysis. Pulmonary Medicine, 2026(1). https://doi.org/10.1155/pm/5113702
Vancouver
Singhal S, Ganga R, Deokar K, Singh J, Jha A, Verma M, et al. Prevalence of Diastolic Dysfunction Among COPD Patients—A Systematic Review and Meta‐Analysis. Pulmonary Medicine. 2026;2026(1). doi:10.1155/pm/5113702
BibTeX
@article{Singhal2026,
author = {Singhal, Sanjay and Ganga, Ranganath and Deokar, Kunal and Singh, Jayvardhan and Jha, Ashish and Verma, Mranalini and Kumar, Anup and Shrivastava, Piyush and Mudgal, Shiv Kumar and Gurjar, Mohan},
title = {Prevalence of Diastolic Dysfunction Among COPD Patients—A Systematic Review and Meta‐Analysis},
journal = {Pulmonary Medicine},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/pm/5113702}
}
EUVIMED